These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7998095)

  • 1. Immunosuppression in small bowel transplantation--treatment with a monoclonal IL-2 receptor antibody (NDS 61).
    Schweizer E; Papachrysanthou A; Faendrich F; Deltz E; Schroeder P
    Transplant Proc; 1994 Dec; 26(6):3142-3. PubMed ID: 7998095
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
    Schmid T; Oberhuber G; Thaler W; Kaltenbacher A; Herbst P; Margreiter R; Konwalinka G
    Transplant Proc; 1994 Jun; 26(3):1614. PubMed ID: 7913269
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats.
    Otto C; Gasser M; Gassel HJ; Steger U; Timmermann W; Meyer D; Ulrichs K; Thiede A
    Transplant Proc; 1998 Aug; 30(5):2161-2. PubMed ID: 9723426
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract]   [Full Text] [Related]  

  • 5. An immunosuppressive regimen that reduces graft cell emigration following small bowel transplantation.
    Clark CL; Crane PW; Cunningham AJ; Wood RF; Lear PA
    Transplant Proc; 1992 Jun; 24(3):1130. PubMed ID: 1604551
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 MAb in rat small bowel transplantation.
    Gasser M; Timmermann W; Vowinkel T; Tykal K; Hoppe H; Otto C; Gassel AM; Meyer D; Ulrichs K; Thiede A
    Transplant Proc; 1998 Sep; 30(6):2605-6. PubMed ID: 9745510
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets.
    Shaffer D; Simpson MA; Milford EL; Gottschalk R; Kut JP; Maki T; Monaco AP
    Transplant Proc; 1991 Feb; 23(1 Pt 1):679-81. PubMed ID: 1990646
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
    Carl S; Wiesel M; Daniel V; Staehler G
    Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined monoclonal antibody therapy in experimental small bowel transplantation.
    Bowles MJ; Wood RF; Pockley AG
    Transplant Proc; 1996 Oct; 28(5):2510. PubMed ID: 8907926
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that 2-chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
    Oberhuber G; Schmid T; Thaler W; Kaltenbacher A; Schirmer M; Liliemark J; Herbst P; Geisen F; Margreiter R; Konwalinka G
    Transplantation; 1994 Sep; 58(6):743-5. PubMed ID: 7940703
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
    Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J
    Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
    Pirenne J; D'Silva M; Jacquet N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of graft infiltrating cells in a rejection model of small bowel transplantation in rats.
    Azuma T; Sarnacki S; Révillon Y; Calise D; Goulet O; Brousse N; Cerf-Bensussan N
    Transplant Proc; 1994 Jun; 26(3):1523-4. PubMed ID: 8030020
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural killer activity is down-regulated following allogeneic small bowel transplantation.
    Tice DG
    Transplant Proc; 1992 Jun; 24(3):1135-6. PubMed ID: 1604554
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.